These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8725995)

  • 1. Didanosine measurement by radioimmunoassay.
    DeRemer M; D'Ambrosio R; Morse GD
    Antimicrob Agents Chemother; 1996 Jun; 40(6):1331-4. PubMed ID: 8725995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of high-dose oral ganciclovir on didanosine disposition in human immunodeficiency virus (HIV)-positive patients.
    Jung D; Griffy K; Dorr A; Raschke R; Tarnowski TL; Hulse J; Kates RE
    J Clin Pharmacol; 1998 Nov; 38(11):1057-62. PubMed ID: 9824788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between didanosine exposure and surrogate marker response in human immunodeficiency virus-infected outpatients.
    Adams JM; Shelton MJ; Hewitt RG; Grasela TH; DeRemer M; Morse GD
    Antimicrob Agents Chemother; 1998 Apr; 42(4):821-6. PubMed ID: 9559790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Didanosine reduces atevirdine absorption in subjects with human immunodeficiency virus infections.
    Morse GD; Fischl MA; Shelton MJ; Borin MT; Driver MR; DeRemer M; Lee K; Wajszczuk CP
    Antimicrob Agents Chemother; 1996 Mar; 40(3):767-71. PubMed ID: 8851608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population pharmacokinetics of didanosine in patients with human immunodeficiency virus infection.
    Harb GE; Mandema JW; Delahunty T; Benowitz NB; Coleman R; Sheiner LB; Jacobson MA
    J Infect Dis; 1996 Jan; 173(1):273. PubMed ID: 8537676
    [No Abstract]   [Full Text] [Related]  

  • 6. A phase-I study of the safety, pharmacokinetics, and antiviral activity of combination didanosine and ribavirin in patients with HIV-1 disease. AIDS Clinical Trials Group 231 Protocol Team.
    Japour AJ; Lertora JJ; Meehan PM; Erice A; Connor JD; Griffith BP; Clax PA; Holden-Wiltse J; Hussey S; Walesky M; Cooney E; Pollard R; Timpone J; McLaren C; Johanneson N; Wood K; Booth D; Bassiakos Y; Crumpacker CS
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Nov; 13(3):235-46. PubMed ID: 8898668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of stavudine and didanosine coadministered with nelfinavir in human immunodeficiency virus-exposed neonates.
    Rongkavilit C; Thaithumyanon P; Chuenyam T; Damle BD; Limpongsanurak S; Boonrod C; Srigritsanapol A; Hassink EA; Hoetelmans RM; Cooper DA; Lange JM; Ruxrungtham K; Phanuphak P
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3585-90. PubMed ID: 11709344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absorption, disposition, and metabolism of [14C]didanosine in the beagle dog.
    Kaul S; Shyu WC; Shukla UA; Dandekar KA; Barbhaiya RH
    Drug Metab Dispos; 1993; 21(3):447-53. PubMed ID: 8100500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Didanosine. An update on its antiviral activity, pharmacokinetic properties and therapeutic efficacy in the management of HIV disease.
    Perry CM; Balfour JA
    Drugs; 1996 Dec; 52(6):928-62. PubMed ID: 8957161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A radioimmunoassay for the new antiviral agent 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil.
    Jagoda E; Ogan M; Stouffer B; Tsay HM; Turabi N; Mantha S; Yost F; Tu JI
    Ther Drug Monit; 1992 Dec; 14(6):499-508. PubMed ID: 1485373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multiple-dose pharmacokinetic interaction study between didanosine (Videx) and ciprofloxacin (Cipro) in male subjects seropositive for HIV but asymptomatic.
    Knupp CA; Barbhaiya RH
    Biopharm Drug Dispos; 1997 Jan; 18(1):65-77. PubMed ID: 9008270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of oral ganciclovir alone and in combination with zidovudine, didanosine, and probenecid in HIV-infected subjects.
    Cimoch PJ; Lavelle J; Pollard R; Griffy KG; Wong R; Tarnowski TL; Casserella S; Jung D
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Mar; 17(3):227-34. PubMed ID: 9495222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pharmacokinetic interaction study of didanosine coadministered with trimethoprim and/or sulphamethoxazole in HIV seropositive asymptomatic male patients.
    Srinivas NR; Knupp CA; Batteiger B; Smith RA; Barbhaiya RH
    Br J Clin Pharmacol; 1996 Mar; 41(3):207-15. PubMed ID: 8866920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic interaction study of indinavir/ritonavir and the enteric-coated capsule formulation of didanosine in healthy volunteers.
    la Porte C; Verweij-van Wissen C; van Ewijk N; Aarnoutse R; Koopmans P; Reiss P; Stek M; Hekster Y; Burger D
    J Clin Pharmacol; 2005 Feb; 45(2):211-8. PubMed ID: 15647414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic interaction between intravenous 2',3'-dideoxyinosine and pentamidine in rats.
    Yeh TK; Kang HJ; Wientjes MG; Au JL
    Pharm Res; 1996 Apr; 13(4):628-32. PubMed ID: 8710758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of zidovudine and didanosine during combination therapy.
    Morse GD; Shelton MJ; Ho M; Bartos L; DeRemer M; Ragni M
    Antiviral Res; 1995 Aug; 27(4):419-24. PubMed ID: 8540760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scintillation proximity radioimmunoassay for the measurement of acyclovir.
    Tadepalli SM; Quinn RP
    J Pharm Biomed Anal; 1996 Nov; 15(2):157-63. PubMed ID: 8933417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-dose pharmacokinetics of enteric-coated didanosine in HIV-infected children.
    King JR; Nachman S; Yogev R; Hodge J; Aldrovandi G; Damle B; Smith E; Wiznia A; Acosta EP
    Antivir Ther; 2002 Dec; 7(4):267-70. PubMed ID: 12553481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Penetration of didanosine in semen of HIV-1-infected men.
    Cruciani M; Liuzzi G; Chirianni A; Audagnotto S; Bonora S; Di Biagio A; Sinicco A; Bassetti M; Gatti G
    J Antimicrob Chemother; 2006 Jun; 57(6):1244-7. PubMed ID: 16556633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-dose pharmacokinetics of delavirdine mesylate and didanosine in patients with human immunodeficiency virus infection.
    Morse GD; Fischl MA; Shelton MJ; Cox SR; Driver M; DeRemer M; Freimuth WW
    Antimicrob Agents Chemother; 1997 Jan; 41(1):169-74. PubMed ID: 8980774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.